Isoform-selective histone deacetylase inhibitors: the trend and promise of disease treatment
Author:
Affiliation:
1. Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, 44 Wenhuaxi Road, Ji'nan, Shandong 250012, PR China
Publisher
Future Medicine Ltd
Subject
Cancer Research,Genetics
Link
https://www.futuremedicine.com/doi/pdf/10.2217/epi.14.62
Reference27 articles.
1. Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
2. Towards Selective Inhibition of Histone Deacetylase Isoforms: What Has Been Achieved, Where We Are and What Will Be Next
3. Towards Isozyme-Selective HDAC Inhibitors For Interrogating Disease
4. Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development
5. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin–TCF interaction
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel histone deacetylase 6 inhibitors using benzimidazole as caps for cancer treatment;New Journal of Chemistry;2023
2. Target Design of Novel Histone Deacetylase 6 Selective Inhibitors with 2-Mercaptoquinazolinone as the Cap Moiety;Molecules;2022-03-28
3. Precision Oncology, Signaling, and Anticancer Agents in Cancer Therapeutics;Anti-Cancer Agents in Medicinal Chemistry;2022-02
4. Marine Power on Cancer: Drugs, Lead Compounds, and Mechanisms;Marine Drugs;2021-08-27
5. Post-translational lysine ac(et)ylation in health, ageing and disease;Biological Chemistry;2021-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3